致在公司集資方麵有心得及有投資意向的朋友們...有企業計劃書及其執行摘要備索。謝謝關注。
公司產品與在研項目：
"We provide modified nucleosides, nucleotides, and phosphoramidites (including triphosphates and phosphoramidites of therapeutic nucleos(t)ides, isotope-labeled nucleotides, fluorescent nucleotides, and nucleotide conjugates) for medical and biotechnological applications in genomics, nucleos(t)ide chemotherapy, oligonucleotide therapy, and diagnostics. With HIV/AIDS, liver disease, and cancer as primary areas of focus, we develop better or alternative chemical processes for nucleoside and nucleotide APIs (active pharmaceutical ingredient), manufacture APIs and related pharmaceutical intermediates, and develop product pipeline of new anti(retro)viral/anticancer agents based on screening of our molecule library of nucleosides and nucleotides by enzymatic assays of corresponding nucleotide triphosphates, and on concepts of nucleotide prodrugs and bifunctional dual drugs."
Look for funds for a startup biotech with therapeutic focus on infectious diseases and cancer. It develops novel nucleoside and nucleotide agents, etc.
